Nasogastric Tube Market By Type (Levin Tube, Salem Sump Tube, Dobhoff Tube, Others), By Material (Polyvinyl Chloride, Silicone, Polyurethane), By Application (Feeding, Medication Administration, Gastric Decompression, Diagnostics & Lavage, Others), By Patient Age Group (Pediatric, Adult, Geriatric), By End User (Hospitals, Ambulatory Surgical Centers, Homecare Settings, Nursing Homes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

Industry Outlook

The Nasogastric Tube market accounted for USD 510.10 Million in 2024 and USD 539.69 Million in 2025 is expected to reach USD 948.4 Million by 2035, growing at a CAGR of around 5.8% between 2025 and 2035. The Nasogastric Tube Market refers to the use of medical devices that are inserted through the nose into the stomach to feed, provide medication, or perform gastrointestinal decompressions. These kinds of tubes are universally applied in the context of critical care, post-operative recovery, and in the case of swallowing disorders.

As the geriatric age group is expanding, the number of gastrointestinal and neurological disorders is increasing, and newer material and insertion methods are being developed in tubes, the market is expected to grow gradually. Due to the increase in the number of patients being admitted into hospitals and the need for home enteral nutrition, growth results as well. Further directions of the future involve designs that are more friendly to the patient and the incorporation of monitoring technologies to improve clinical outcomes.

Industry Experts Opinion

"Nasogastric tubes remain a critical tool in clinical nutrition, especially for patients with dysphagia or gastrointestinal obstructions. The shift toward antimicrobial-coated tubes has significantly reduced hospital-acquired infections."

• Dr. John Smith, MD, Gastroenterologist, Mayo Clinic

Report Scope:

Market Dynamics

The growing geriatric population increases demand for enteral feeding and gastric decompression interventions.

Attributable to the extremely rising population of the ageing people in the world, the Nasogastric Tube Market is growing fast. Aged people are susceptible to such illnesses as dysphagia, stroke, dementia, and other neurological disorders that hinder the process of swallowing, and in such cases, enteral feeding solutions such as nasogastric tubes are widely used. It also causes a rise in hospitalization, surgery, and ICU admissions, where nasogastric tubes are commonly adopted to decompress the stomach and allow nutritional support. With age, the need for individuals to receive regular and extended medical care increases, especially through tube feeding to ensure long-term nutritional intake. This population dynamic makes the nasogastric tube a vital instrument in geriatric healthcare management. 

However, this also raises concerns about patient safety and care quality. For instance, in Brazil, 43% of older patients using NGT or nasoenteric tubes experienced at least one adverse incident, with 28.7% facing unplanned removals, most resulting in mild harm. Such data highlights the importance of developing safer, more comfortable designs tailored for elderly use. Consequently, there is a growing demand for tubes made from softer materials and designed for ease of use, aiming to enhance patient comfort and minimize the risk of complications. Thus, the increasing number of elderly individuals continues to be a significant driver of long-term growth in the Nasogastric Tube Market, particularly in developed countries with well-established healthcare systems.

The rising prevalence of gastrointestinal disorders necessitates the use of NG tubes in clinical management.

The rising prevalence rate of gastrointestinal (GI) diseases like gastroparesis, intestinal obstruction, gastroesophageal reflux disease (GERD), and GI cancers are increasing factors which are driving the Nasogastric Tube Market. These conditions most of the time compromise the digestive process or necessitate the decompression of the gastric as well as the provision of enteral nutrition, which mainly depends on the insertion of the NG tubes. GI problems are on the increase because of the sedentary ways of living, poor dietary lifestyles, and the increasing levels of stress. Globally, there has been a rise in hospitalizations as a result of GI emergencies, propelling the clinical need for a nasogastric tube.

In addition, nasogastric intubation can be used as a primary method in the treatment process of acute abdominal signs or the rehabilitation of the bowel after surgery. An increased usage of endoscopic procedures and laparoscopic surgery equally adds to the application of the NG tube in pre- and post-surgical care of a patient. Such tubes are frequently used by physicians to treat symptoms, such as nausea, vomiting, or gastric bloating, and, therefore, are clinically relevant. The treatment of medications for patients who have problems with their upper GI tract is also administered with the help of NG tubes. More cases are being diagnosed early, yet with superior awareness and diagnostics, providing constant demand.

The risk of complications like nasal irritation, aspiration, or misplacement limits wider adoption.

Although the application of a nasogastric tube is widely used, competition in the Nasogastric Tube Market is hindered by the possibility of related complications. Although there is generally no harm attached to the insertion of the NG tube, there are several demerits that may follow its insertion, including, but not limited to, nasal irritation, mucosal damage, sore throat, sinusitis, and, in the worst case, Esophageal perforation. Wrong insertion of the tube into the respiratory system can cause aspiration pneumonia- a severe disease, more so when a patient is critically sick or aged. They require well-qualified health workers to perform it safely and correctly, so it is inappropriate when there is no proper supervision or when there are insufficient resources for the intervention.

Besides, long-term treatment with a nasogastric tube may result in discomfort and failure to cooperate by the patient, especially in long-term care settings. These difficulties can lead clinicians to think about such subsequent procedures as percutaneous endoscopic gastrostomy (PEG) when long-term requirements occur. It is also possible that some patients have tube blockage or dislodgment, which leads to repeated procedures, and this increases the medical costs. Consequently, medical professionals can take precautions or wait to use it as a last resort. This safety issue may restrict the prospects in the Nasogastric Tube Market, especially in markets with their lack of training or other infrastructure.

The growing home healthcare market opens new avenues for long-term enteral feeding solutions.

The healthcare industry is growing and gaining pace, which is a positive prospect for the nasogastric tube. With rising healthcare expenses and the wish of patients to be in comfort and convenience, the number of patients seeking home-based services is on the rise. The use of nasogastric tubes in home care, especially with patients who are medically stable and who need long-term nutrition support, is a widespread occurrence in the home care setting. The trend towards home care and hospital care is particularly high in developed countries with a well-developed system of home care and with an insurance system. The new improved NG tubes are patient-friendly and are being designed with softer materials and simpler modes of insertion to enable their application at home.

There is better patient compliance as family and patient caregivers are being trained to deal with feeding and maintenance. The safety of household use of nasogastric tubes is also being improved by telemedicine and remote monitoring technology. Also, it is made available online at online medical supplies, where the NG tube kit can be easily sourced. Governments or healthcare providers are also promoting home care so as to decongest hospitals. This trend is likely to have a upside effect on the nasogastric tube market since it will attract more demand to the market outside of the usual clinical grounds.

Technological innovations like sensor-enabled NG tubes offer real-time placement and safety assurance.

New opportunities in the Nasogastric Tube Market are brought about by technological improvements in nasogastric tubes, especially safety and efficiency. More recent developments have seen the invention of sensor-based tubes that enable real-time verification of proper insertion, minimizing the chances of insertion errors and subsequent complications. Complex designs incorporating either pH sensors or electromagnetic guidance systems allow precise positioning into the gastric cavity without requiring repetitive X-ray guidance. These features are particularly relevant in emergency environments and when dealing with pediatric or geriatric patients, where precision is of high importance. Notably, in critically ill adults at high nutritional risk, achieving at least 65% of energy targets by day 3 through early nasogastric or small-bowel feeding has been associated with significantly reduced hospital mortality (adjusted HR ≈ 2.3), highlighting the clinical value of timely and efficient enteral feeding.

Improvements in long-term tolerability and reduced patient discomfort have also been achieved through material innovations, including the use of biocompatible silicone and less-stiff polyurethane. More reliable designs, such as anti-clogging features and specialized coatings, further prolong tube usability. In addition, manufacturers are incorporating advanced connectors that reduce leakage and the risk of contamination. These user-centric enhancements make the devices more attractive to clinicians and caregivers alike. With the rising demand for safer and superior medical devices, the nasogastric tube industry stands to benefit from the emergence of this new generation of advanced devices.

Segment Analysis

Based on the Type, the Nasogastric Tube Market is classified into Levin Tube, Salem Sump Tube, Dobhoff Tube, and Others. The Salem Sump Tube segment is the largest because the synthetic tube has a dual-lumen tube that enables both suction and venting to be done concurrently. This decreases mucosal damage, and this aspect makes it a favored option during emergencies and in intensive care areas.

The adherence rate is high because of its safety and cementation to the unstoppered gastric decompression in hospitals. As much as the Levin tubes are widely used, they are primarily short-term. There is growing popularity with the Dobhoff tubes that have softer and weighted tips in long-term feeding, but in most special situations, such as home care or chronic illness. With the increase in the number of critical care admissions across the world, the demand for Salem Sump tubes should be sustained.

Based on the Material, the Nasogastric Tube Market is classified as Polyvinyl Chloride, Silicone, and Polyurethane. Polyvinyl Chloride (PVC) takes major stakes in the market because of the low cost, malleability, and universal availability. PVC tubes are regarded as essential hospital products because acute care utilizes PVC tubes in short-term feeding and decompression.

Nonetheless, the silicone and polyurethane segments are increasing at a fast rate, owing to the excellent biocompatibility, softness, as well as the capability to be worn on a long-term basis, especially among children and ageing patients. The silicone tubes are more comfortable to the patient; polyurethane is thinner and stronger, and therefore permits high flow rates. Though PVC is already dominating in terms of volume, the trends of patient-centred and long-term care slowly add demand to other materials.

Regional Analysis

North America Nasogastric Tube Market is the largest market due to its developed healthcare facilities, elevated level of hospitalization, and having a larger base of major players in the medical device industry. Well-developed reimbursement policies, rising popularity of home healthcare, and the high population of older adults who need enteral feeding products help the region. The U.S., specifically, has a huge market share because of a wide range of critical care services and early use of advanced medical technology. Also, effective regulation and health care specialists facilitate the extensive and secure application of nasogastric tubes. The constant innovation and clinical research also support the leadership position of North America in the market.

Asia-Pacific Nasogastric Tube Market is the fastest-growing owing to the increasing geriatric population, growing investments towards healthcare, and increasing access to healthcare. There is an increasing number of hospitalizations related to chronic diseases in countries such as China, India, and Japan, and hence an increased need for NG tubes. The rate of rapid urbanization is one of the factors, the increased attention to enteral feeding and the development of healthcare infrastructure all play a role in this fast development. Moreover, affordability and availability are being empowered by government plans to invest in patient care and manufacturing capacities in the countries. Due to the changes in healthcare systems, in the future, Asia-Pacific is likely to determine the developmental direction of the market.

Competitive Landscape

The Nasogastric Tube Market has a moderately competitive environment with some major players owning large global market shares due to their product portfolio and strategic alliances. Giant business organizations like Cardinal Health, Medtronic, BD (Becton, Dickinson and Company), B. Braun Melsungen, and Teleflex are giants of the market that rely on constant innovation in terms of their products and active international networks of distribution. The feature of these players is the ability to work on the development of advanced NG tubes that can consist of biocompatible materials such as silicone and polyurethane to increase the comfort of patients and minimize complications.

Avanos Medical and Vygon are improving their presence by introducing NG tubes with anti-clogging characteristics and radiopaque markers so that safer deployment can be done. Some of the most important strategies in the market are product differentiation, technological innovation, mergers and acquisitions, and entering into new markets such as Asia-Pacific and Latin America. There are also many players funding decentralized care-friendly NG tube kits, as the costs align with this new trend of home care. Other local manufacturers in countries such as India and China, such as Romsons and SURU International, are catching up with cost-effective products and regulatory approvals. On the whole, the competition is rising, and the companies struggle to achieve an adequate balance between prices, quality, and convenience to intrude more significantly into the marketplace.

Nasogastric Tube Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Recent Developments:

• In March 2024, Avanos Medical introduced its next-generation Cortrak® 2 Enteral Access System, featuring enhanced electromagnetic tracking for more accurate NG tube placement.
  This innovation aims to reduce misplacement risks and improve patient safety during nasogastric tube procedures.
• In December 2023, Teleflex launched a new Dobbhoff™ NG Tube with improved material durability and radiopaque markers. The enhancement is designed to offer better visibility under imaging and increased patient comfort during enteral feeding procedures.

Report Coverage:

By Type

• Levin Tube
• Salem Sump Tube
• Dobhoff Tube
• Others

By Material

• Polyvinyl Chloride
• Silicone
• Polyurethane

By Application

• Feeding
• Medication Administration
• Gastric Decompression
• Diagnostics & Lavage
• Others

By Patient Age Group

• Pediatric
• Adult
• Geriatric

By End User

• Hospitals
• Ambulatory Surgical Centers
• Homecare Settings
• Nursing Homes
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• Cardinal Health
• Medtronic
• BD
• B. Braun Melsungen
• Teleflex
• Vygon
• Avanos Medical
• Smith’s Medical
• Romsons
• Halyard Health
• SURU International
• Fresenius Kabi
• QMD
• Andersen Products
• KindWell Medical

Frequently Asked Questions (FAQs)